EP
INBX icon

Essential Partners’s Inhibrx INBX Stock Holding History

Essential Partners’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$200 Hold
2
– – ﹤0.01% 2595
2026
Q2 		$190 Hold
2
– – ﹤0.01% 2648
2026
Q1 		$134 Hold
2
– – ﹤0.01% 2675
2025
Q4 		$158 Hold
2
– – ﹤0.01% 2474
2025
Q3 		$67 Hold
2
– – ﹤0.01% 2539
2025
Q2 		$29 Buy
+2
New +$26 ﹤0.01% 2197

Other funds holding INBX

Tema ETFs
Tema ETFs New York $2.69B AUM 42.96% 1-Year Est. Return
Dynamic Advisor Solutions
Dynamic Advisor Solutions Phoenix, Arizona $3.52B AUM 15.33% 1-Year Est. Return
PA
Persium Advisors Atlanta, Georgia $191M AUM 23.01% 1-Year Est. Return
Independent Financial Group
Independent Financial Group San Diego, California $5.51B AUM 33.52% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
FIA
FNY Investment Advisers New York $402M AUM 85.34% 1-Year Est. Return
Versant Capital Management
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
Blue Trust Inc
Blue Trust Inc Alpharetta, Georgia $9.5B AUM 13.02% 1-Year Est. Return
CoreCap Advisors
CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return

Essential Partners's INBX Position: Q3 2026 in Review

Essential Partners held its Inhibrx (INBX) position steady in Q3 2026 at 2 shares worth $200. The position accounts for ﹤0.01% of the portfolio, ranked #2595.

Essential Partners first reported a position in INBX in Q2 2025 and has held it in 6 quarters since. 11 funds tracked by Wall St. Rank hold INBX as of Q3 2026.

  • Essential Partners held 2 shares of Inhibrx worth $200 as of Q3 2026.
  • Essential Partners left its Inhibrx share count unchanged in Q3 2026.
  • Inhibrx made up ﹤0.01% of Essential Partners's portfolio in Q3 2026, its #2595 holding.
  • Essential Partners first reported a position in Inhibrx in Q2 2025 and has held it in 6 quarters since.
  • 11 funds tracked by Wall St. Rank held Inhibrx as of Q3 2026.

Based on Essential Partners's 13F filing for Q3 2026, filed 14 Oct 2026.